Cargando…

Delivery of Rapamycin by Liposomes Synergistically Enhances the Chemotherapy Effect of 5-Fluorouracil on Colorectal Cancer

BACKGROUND: Rapamycin is a promising agent for treating tumors, but clinical applications of rapamycin are limited due to its poor water solubility and low bioavailability. This paper constructs a liposome delivery system for rapamycin to improve the effect in treating colorectal cancer. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yi-Qing, Zhu, Wen-Ting, Lin, Cai-Yan, Yuan, Zhong-Wen, Li, Zhen-Hua, Yan, Peng-Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811466/ https://www.ncbi.nlm.nih.gov/pubmed/33469286 http://dx.doi.org/10.2147/IJN.S270939

Ejemplares similares

Rapamycin Liposomes Combined with 5-Fluorouracil Inhibits Angiogenesis and Tumor Growth of APC ((Min/+)) Mice and AOM/DSS-Induced Colorectal Cancer Mice
por: Liu, Xiao-Min, et al.
Publicado: (2022)

Effective Attenuation of Arteriosclerosis Following Lymphatic-Targeted Delivery of Hyaluronic Acid-Decorated Rapamycin Liposomes
por: Liu, Xiaojia, et al.
Publicado: (2023)

Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma
por: Liu, Sai-Lan, et al.
Publicado: (2018)

Glycol Chitosan-Docosahexaenoic Acid Liposomes for Drug Delivery: Synergistic Effect of Doxorubicin-Rapamycin in Drug-Resistant Breast Cancer
por: Kim, Min Woo, et al.
Publicado: (2019)

Preparation of a liposomal delivery system and its in vitro release of rapamycin
por: MIAO, ZHI-LIN, et al.
Publicado: (2015)

Rapamycin in lipoproteins for enhanced delivery
por: Cho, Kyung-Hyun
Publicado: (2012)

Co-delivery of Cisplatin and Rapamycin for Enhanced Anticancer Therapy through Synergistic Effects and Microenvironment Modulation
por: Guo, Shutao, et al.
Publicado: (2014)

PNA-Modified Liposomes Improve the Delivery Efficacy of CAPIRI for the Synergistic Treatment of Colorectal Cancer
por: Diao, Wenbin, et al.
Publicado: (2022)

Synergistic antitumor effect of 5-fluorouracil with the novel LSD1 inhibitor ZY0511 in colorectal cancer
por: Peng, Wen, et al.
Publicado: (2020)

Combining the mammalian target of rapamycin inhibitor, rapamycin, with resveratrol has a synergistic effect in multiple myeloma
por: Jin, Hong-Guang, et al.
Publicado: (2018)

Co-delivery of docetaxel and palmitoyl ascorbate by liposome for enhanced synergistic antitumor efficacy
por: Li, Junxiu, et al.
Publicado: (2016)

In situ delivery of thermosensitive gel-mediated 5-fluorouracil microemulsion for the treatment of colorectal cancer
por: Wang, Lu-Lu, et al.
Publicado: (2016)

Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer
por: Huang, Xingxing, et al.
Publicado: (2022)

Liposomal delivery and polyethylene glycol-liposomal oxaliplatin for the treatment of colorectal cancer (Review)
por: YANG, CHUANG, et al.
Publicado: (2014)

Liposomal 5-Fluorouracil Polymer Complexes Facilitate Tumor-Specific Delivery: Pharmaco-Distribution Kinetics Using Microdialysis
por: Wang, Wen, et al.
Publicado: (2022)

Sustained co-delivery of 5-fluorouracil and cis-platinum via biodegradable thermo-sensitive hydrogel for intraoperative synergistic combination chemotherapy of gastric cancer
por: Chen, Wen, et al.
Publicado: (2022)

Synergistic Combination of Irinotecan and Rapamycin Orally Delivered by Nanoemulsion for Enhancing Therapeutic Efficacy of Pancreatic Cancer
por: Liu, Yu-Hsuan, et al.
Publicado: (2023)

Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel
por: Yoon, Ho Yub, et al.
Publicado: (2019)

Enhancement of cisplatin sensitivity in lewis lung carcinoma by liposome-mediated delivery of a survivin mutant
por: Yu, Dan-Dan, et al.
Publicado: (2010)

Synergistic Antitumor Effect of Dichloroacetate in Combination with 5-Fluorouracil in Colorectal Cancer
por: Tong, Jingtao, et al.
Publicado: (2011)

Enhanced in Vivo Delivery of 5-Fluorouracil by Ethosomal Gels in Rabbit Ear Hypertrophic Scar Model
por: Wo, Yan, et al.
Publicado: (2014)

Targeted delivery of 5-fluorouracil, miR-532-3p, and si-KRAS to the colorectal tumor using layer-by-layer liposomes
por: Shahidi, Maryamsadat, et al.
Publicado: (2022)

Permeability-Enhanced Liposomal Emulgel Formulation of 5-Fluorouracil for the Treatment of Skin Cancer
por: Pachauri, Ankur, et al.
Publicado: (2023)

Diosmetin Exerts Synergistic Effects in Combination with 5-Fluorouracil in Colorectal Cancer Cells
por: Kamran, Sareh, et al.
Publicado: (2022)

In Vitro Assessment of the Synergistic Effect of Aspirin and 5-Fluorouracil in Colorectal Adenocarcinoma Cells
por: Susan, Monica, et al.
Publicado: (2023)

Synergistic photothermal-photodynamic-chemotherapy toward breast cancer based on a liposome-coated core–shell AuNS@NMOFs nanocomposite encapsulated with gambogic acid
por: Li, Rong-Tian, et al.
Publicado: (2022)

Synergistic effect of puerarin and 5-fluorouracil on hepatocellular carcinoma
por: ZENG, YAN-PING, et al.
Publicado: (2014)

The use of chitosan-coated flexible liposomes as a remarkable carrier to enhance the antitumor efficacy of 5-fluorouracil against colorectal cancer
por: Alomrani, Abdullah, et al.
Publicado: (2019)

Treatment of Colorectal Cancer Using a Combination of Liposomal Irinotecan (Irinophore C™) and 5-Fluorouracil
por: Hare, Jennifer I., et al.
Publicado: (2013)

Co-Delivery of 5-Fluorouracil and Paclitaxel in Mitochondria-Targeted KLA-Modified Liposomes to Improve Triple-Negative Breast Cancer Treatment
por: Chen, Tianyu, et al.
Publicado: (2022)

Synergistic enhancement of 5-fluorouracil cytotoxicity by deoxyuridine analogs in cancer cells
por: Matsumoto, Yoshihiro, et al.
Publicado: (2015)

Linalool-Incorporated Synergistically Engineered Modified Liposomal Nanocarriers for Enhanced Transungual Delivery of Terbinafine against Onychomycosis
por: Gupta, Isha, et al.
Publicado: (2023)

Anemoside B4 sensitizes human colorectal cancer to fluorouracil-based chemotherapy through src-mediated cell apoptosis
por: He, Xing, et al.
Publicado: (2021)

The Effect of Compound Sophora on Fluorouracil and Oxaliplatin Resistance in Colorectal Cancer Cells
por: Yin, WeiHua, et al.
Publicado: (2019)

MicroRNA‐375‐3p enhances chemosensitivity to 5‐fluorouracil by targeting thymidylate synthase in colorectal cancer
por: Xu, Fei, et al.
Publicado: (2020)

Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer
por: Akkın, Safiye, et al.
Publicado: (2023)

Enhanced efficacy with reduced toxicity of chemotherapy drug 5-fluorouracil by synergistic treatment with Abnormal Savda Munziq from Uyghur medicine
por: Yang, Tao, et al.
Publicado: (2017)

Oxymatrine Synergistically Enhances Doxorubicin Anticancer Effects in Colorectal Cancer
por: Pan, Di, et al.
Publicado: (2021)

Metal-fluorouracil networks with disruption of mitochondrion enhanced ferroptosis for synergistic immune activation
por: Lei, Lingling, et al.
Publicado: (2022)

LINC00957 Acted as Prognostic Marker Was Associated With Fluorouracil Resistance in Human Colorectal Cancer
por: Zhang, Li Hua, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f08s507cbaf3v4o2hd6fqs9dct